Abuse-deterrent opioids: an update on current approaches and considerations.

about

and Pharmacological Activities of 14--Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice

P2860

Q57095558-43EE0675-B2D3-4B32-9848-21A00965094C

P2860

Abuse-deterrent opioids: an update on current approaches and considerations.

Item

http://www.wikidata.org/entity/Q47274936

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Abuse-deterrent opioids: an update on current approaches and considerations.

@en

Abuse-deterrent opioids: an update on current approaches and considerations.

@nl

type

Item

label

Abuse-deterrent opioids: an update on current approaches and considerations.

@en

Abuse-deterrent opioids: an update on current approaches and considerations.

@nl

prefLabel

Abuse-deterrent opioids: an update on current approaches and considerations.

@en

Abuse-deterrent opioids: an update on current approaches and considerations.

@nl

P1476

Abuse-deterrent opioids: an update on current approaches and considerations.

@en

P2093

Joseph V Pergolizzi

http://www.w3.org/2001/XMLSchema#string

Robert B Raffa

http://www.w3.org/2001/XMLSchema#string

Robert Taylor

http://www.w3.org/2001/XMLSchema#string

Steven Vacalis

http://www.w3.org/2001/XMLSchema#string

P2860

Relationship between Nonmedical Prescription-Opioid Use and Heroin Use

Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States

Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics.

Secular trends in opioid prescribing in the USA.

Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users.

Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation.

Initiation into prescription opioid misuse amongst young injection drug users

Abuse-deterrent formulations: transitioning the pharmaceutical market to improve public health and safety.

Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users.

Can abuse deterrent formulations make a difference? Expectation and speculation.

P304

1-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/03007995.2017.1419171

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29262730

http://www.w3.org/2001/XMLSchema#string

Abuse-deterrent opioids: an update on current approaches and considerations.

about

P2860

P2860

Abuse-deterrent opioids: an update on current approaches and considerations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P577

P698